MX2007005121A - Composicion que comprende acetaminofen, cafeina y opcionalmente aspirina junto con un agente alcalino para mejorar la absorcion. - Google Patents

Composicion que comprende acetaminofen, cafeina y opcionalmente aspirina junto con un agente alcalino para mejorar la absorcion.

Info

Publication number
MX2007005121A
MX2007005121A MX2007005121A MX2007005121A MX2007005121A MX 2007005121 A MX2007005121 A MX 2007005121A MX 2007005121 A MX2007005121 A MX 2007005121A MX 2007005121 A MX2007005121 A MX 2007005121A MX 2007005121 A MX2007005121 A MX 2007005121A
Authority
MX
Mexico
Prior art keywords
composition
acetaminophen
caffeine
alkiline
agent
Prior art date
Application number
MX2007005121A
Other languages
English (en)
Spanish (es)
Inventor
Rong Liu
Michael Corbo
Jatin Desai
Gerard P Frunzi
Xiaohong Qi
Candice Y Choi
Rahul R Gandhi
Atef Z Boulos
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2007005121A publication Critical patent/MX2007005121A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2007005121A 2004-10-28 2005-10-26 Composicion que comprende acetaminofen, cafeina y opcionalmente aspirina junto con un agente alcalino para mejorar la absorcion. MX2007005121A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62281204P 2004-10-28 2004-10-28
PCT/US2005/038507 WO2006049978A1 (en) 2004-10-28 2005-10-26 Composition comprising acetaminophen, caffeine and optionally aspirin together with an alkiline agent fr enhanced absorption

Publications (1)

Publication Number Publication Date
MX2007005121A true MX2007005121A (es) 2007-06-22

Family

ID=35744599

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007005121A MX2007005121A (es) 2004-10-28 2005-10-26 Composicion que comprende acetaminofen, cafeina y opcionalmente aspirina junto con un agente alcalino para mejorar la absorcion.

Country Status (17)

Country Link
US (1) US20070298096A1 (cg-RX-API-DMAC7.html)
EP (1) EP1807068B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008518914A (cg-RX-API-DMAC7.html)
CN (1) CN101048155A (cg-RX-API-DMAC7.html)
AR (1) AR051145A1 (cg-RX-API-DMAC7.html)
AT (1) ATE460930T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005302618B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0520000A2 (cg-RX-API-DMAC7.html)
CA (1) CA2583517C (cg-RX-API-DMAC7.html)
DE (1) DE602005020048D1 (cg-RX-API-DMAC7.html)
MX (1) MX2007005121A (cg-RX-API-DMAC7.html)
NO (1) NO20072255L (cg-RX-API-DMAC7.html)
PE (1) PE20061125A1 (cg-RX-API-DMAC7.html)
PL (1) PL1807068T3 (cg-RX-API-DMAC7.html)
PT (1) PT1807068E (cg-RX-API-DMAC7.html)
RU (1) RU2398571C2 (cg-RX-API-DMAC7.html)
WO (1) WO2006049978A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0607085D0 (en) 2006-04-07 2006-05-17 Smithkline Beecham Corp Novel compositions
CN100417385C (zh) * 2006-09-26 2008-09-10 林星 一种用于治疗外伤的外用制剂
GB0707489D0 (en) * 2007-04-18 2007-05-23 Renaissance Pharma Compounds
CN101596163B (zh) * 2008-06-06 2012-06-27 康美保宁(四川)制药有限公司 阿咖酚微丸制剂及其制备方法
GB0813929D0 (en) * 2008-07-30 2008-09-03 Glaxo Group Ltd Novel method
CN102861040B (zh) * 2012-08-02 2014-04-23 广东环球制药有限公司 含有阿司匹林、对乙酰氨基酚和咖啡因的药物组合物及其制备方法
CN102949401A (zh) * 2012-09-06 2013-03-06 广东九明制药有限公司 对乙酰氨基酚、乙酰水杨酸和咖啡因组合物及其制备工艺
US10124005B1 (en) * 2017-12-15 2018-11-13 Lisa Josette Myslinski Multisymptom migraine combination medication
CN110711197B (zh) * 2018-07-12 2023-11-24 北京恒润泰生医药科技有限公司 阿司匹林和对乙酰氨基酚的分子复合物加咖啡因,其制备,活性及应用
CN108853124A (zh) * 2018-08-15 2018-11-23 康美保宁(四川)制药有限公司 一种阿咖酚制剂及其制剂方法
GB202007670D0 (en) * 2020-05-22 2020-07-08 Glaxosmithkline Consumer Healthcare Holdings Us Llc Pharmaceutical composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294819A (en) * 1980-08-18 1981-10-13 Bristol-Myers Company Alkaline analgesic capsule
CA1182049A (en) * 1981-07-13 1985-02-05 Francis J. Sterbenz Apap antacid composition
US5296241A (en) * 1991-04-03 1994-03-22 Brimberg Barnett J Therapeutic composition and method of using same for treatment of hangover
JP3122748B2 (ja) * 1991-11-29 2001-01-09 ライオン株式会社 イブプロフェン含有解熱鎮痛剤
JP3172749B2 (ja) * 1992-02-17 2001-06-04 ライオン株式会社 イブプロフェン含有製剤
JPH06227995A (ja) * 1993-02-03 1994-08-16 Takeda Chem Ind Ltd 安定化された固型製剤
JPH07206689A (ja) * 1994-01-21 1995-08-08 Barnett Lab Ltd 治療組成物および宿酔の治療のためのこの組成物の使用法
DE19502789A1 (de) * 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel
RU2101014C1 (ru) * 1995-09-07 1998-01-10 Акционерное общество "Курский комбинат лекарственных средств" Анальгезирующее, противовоспалительное, жаропонижающее лекарственное средство и способ его получения
GB9704524D0 (en) * 1997-03-05 1997-04-23 Smithkline Beecham Plc Composition
US5972916A (en) * 1997-07-14 1999-10-26 Bristol-Myers Squibb Company Compositions containing the nonprescription combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine
JP2002012557A (ja) * 2000-06-28 2002-01-15 Lion Corp 内服薬組成物
US20040147606A1 (en) * 2001-05-25 2004-07-29 Yoichi Onuki Medicinal compositions
JP4553552B2 (ja) * 2003-01-08 2010-09-29 日東薬品工業株式会社 生体リズム応用キット

Also Published As

Publication number Publication date
AR051145A1 (es) 2006-12-20
PT1807068E (pt) 2010-04-19
US20070298096A1 (en) 2007-12-27
EP1807068B1 (en) 2010-03-17
BRPI0520000A2 (pt) 2009-04-07
PE20061125A1 (es) 2006-11-08
AU2005302618A1 (en) 2006-05-11
RU2007119641A (ru) 2008-12-10
RU2398571C2 (ru) 2010-09-10
EP1807068A1 (en) 2007-07-18
ATE460930T1 (de) 2010-04-15
WO2006049978A1 (en) 2006-05-11
CA2583517A1 (en) 2006-05-11
AU2005302618B2 (en) 2009-10-22
CA2583517C (en) 2013-06-04
CN101048155A (zh) 2007-10-03
PL1807068T3 (pl) 2010-08-31
DE602005020048D1 (de) 2010-04-29
JP2008518914A (ja) 2008-06-05
NO20072255L (no) 2007-07-18

Similar Documents

Publication Publication Date Title
NO20072255L (no) Sammensetning omfattende acetaminofen, koffein og valgfritt aspirin sammen med et alkalisk middel for forbedret absorpsjon
DE60331153D1 (de) Reboxetin enthaltende tablette mit verzögerter wirkstoffabgabe
MX2007000564A (es) Metodo para utilizar efectivamente medicamentos referentes a la prevencion de efectos secundarios.
WO2002002093A3 (en) Combination containing an antifolate and methylmalonic acid lowering agent
BRPI0514474A (pt) multiparticulados
ES2162517T3 (es) Composicion farmaceutica que comprende una combinacion de metformin y fibrato y su uso en la preparacion de medicamentos destinados a reducir la hiperglicemia.
DK1603565T3 (da) Medikament omfattende en höjaktiv længevarende beta2-agonisk i kombination med andre aktive ingredienser
AR049083A1 (es) Proceso para la preparacion de una forma de dosificacion solida a prueba de abuso
DE60316552D1 (de) Tablette mit hohem wirkstoffgehalt
WO2006031878A3 (en) Imidazoquinoline compounds
BR0317924A (pt) Formas de dosagem não aquosas de composto de prostaglandina e
AR053541A1 (es) Combinacion de xolair con agente inmunosupresor
WO2004022002A3 (en) Combined immediate release and extended release analgesic composition
BRPI0410808A (pt) (1s,5s)-3- (5,6-dicloro-3-piridinil)-3,6-diazabiciclo[3.2.0]heptano como um agente analgésico eficaz
DE502005007425D1 (de) Pharmazeutische zusammensetzungen, die diaminooxidase enthalten
DE602004014964D1 (de) Pharmazeutische zusammensetzung mit einem kationischen hilfsmittel
WO2006107316A8 (en) Improved formulations of fenofibrate containing menthol or peg/poloxamer
WO2008100240A3 (en) Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
CA2554751A1 (en) Anti-inflammatory analgesic for external use
ITRM20040607A1 (it) Analoghi della dermorfina ad attivita' analgesica.
SE0000303D0 (sv) Novel compounds
ITMI20030972A1 (it) Indazolo dotato di attivita' analgesica, metodo per prepararlo e composizione farmaceutica che lo comprende.
CR8973A (es) Composicion farmaceutica en forma de una forma de dosificacion solida soluble en agua
DK1537132T3 (da) Salt af mortin-6-glucuronid
SV2006002224A (es) Composicion farmaceutica ref. bhco41368-sv

Legal Events

Date Code Title Description
FG Grant or registration